Aadi Bioscience Announces Participation in Upcoming September Investor Conferences
- Citi's 17th Annual
BioPharma Conference ,September 7-8, 2022 , inBoston, MA - Morgan Stanley's 20th Annual Global Healthcare Conference,
September 12-14, 2022 , inNew York, NY Neil Desai , Ph.D., Aadi Bioscience Founder and CEO, will take part in a 30-minute fireside chat onWednesday, September 14 th at2:55 pm ET - A live webcast of the fireside chat will be available on the Investors & News page of the Company's website
H.C. Wainwright's 24th AnnualGlobal Investment Conference ,September 12-14, 2022 , inNew York, NY - A pre-recorded presentation will be available on the Investors & News page of the Company's website on
Monday, September 12 at7:00 am ET Ladenburg Thalmann's 2022 Healthcare Conference,September 29, 2022 , inNew York, NY Neil Desai , Ph.D., Aadi Bioscience Founder and CEO, will give a brief presentation followed by an analyst-led fireside chat from9:00 am –9:25 am ET - A live webcast of the presentation will be available on the Investors & News page of the Company's website
Replays of webcasts will be available for approximately 30 days following each presentation.
About Aadi Bioscience
Aadi is a commercial-stage biopharmaceutical company focused on precision therapies for genetically defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. In
Based on exploratory data from AMPECT, a registrational study supporting approval in advanced malignant PEComa, and following a pre-IND meeting with the FDA, Aadi has initiated PRECISION 1, a Phase 2 tumor-agnostic registration-intended trial in mTOR inhibitor-naïve malignant solid tumors harboring TSC1 or TSC2 inactivating alterations. More information on the Company's development pipeline is available on the Aadi website at www.aadibio.com and connect with us on Twitter and LinkedIn.
Contact:
IR@aadibio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/aadi-bioscience-announces-participation-in-upcoming-september-investor-conferences-301615912.html
SOURCE